News

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
MONROE, La. (KNOE) - Finding natural ways to increase glucagon-like peptide-1, otherwise known as GLP-1, can be very beneficial in helping treat type 2 diabetes and obesity. St. Francis Medial ...
The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...
Diabetes, weight-loss meds ‘out of reach’ for many, I-MAK says Firms defend actions; Lilly calls report ‘grossly inaccurate’ Novo Nordisk A/S and Eli Lilly & Co. are using dense clusters of patents to ...
Now some doctors are trying GLP-1 drugs — popular medications for weight-loss and Type 2 diabetes — as part of lymphedema therapy and seeing promising results. Beccarelli was prescribed the ...
GLP-1's are a category of prescription medications labeled as glucagon-like peptide-1's. They're offered in several brand name forms, like Ozempic, where semaglutide is the main substance ...
33,950 people played the daily Crossword recently. Can you solve it faster than others?33,950 people played the daily Crossword recently. Can you solve it faster than others?